The impact of long-term conditions on disability-free life expectancy: A systematic review.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
01
2022
accepted:
14
06
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Although leading causes of death are regularly reported, there is disagreement on which long-term conditions (LTCs) reduce disability-free life expectancy (DFLE) the most. We aimed to estimate increases in DFLE associated with elimination of a range of LTCs. This is a comprehensive systematic review and meta-analysis of studies assessing the effects of LTCs on health expectancy (HE). MEDLINE, Embase, HMIC, Science Citation Index, and Social Science Citation Index were systematically searched for studies published in English from July 2007 to July 2020 with updated searches from inception to April 8, 2021. LTCs considered included: arthritis, diabetes, cardiovascular disease including stroke and peripheral vascular disease, respiratory disease, visual and hearing impairment, dementia, cognitive impairment, depression, cancer, and comorbidity. Studies were included if they estimated HE outcomes (disability-free, active or healthy life expectancy) at age 50 or older for individuals with and without the LTC. Study selection and quality assessment were undertaken by teams of independent reviewers. Meta-analysis was feasible if three or more studies assessed the impact of the same LTC on the same HE at the same age using comparable methods, with narrative syntheses for the remaining studies. Studies reporting Years of Life Lost (YLL), Years of Life with Disability (YLD) and Disability Adjusted Life Years (DALYs = YLL+YLD) were included but reported separately as incomparable with other HE outcomes (PROSPERO registration: CRD42020196049). Searches returned 6072 unique records, yielding 404 eligible for full text retrieval from which 30 DFLE-related and 7 DALY-related were eligible for inclusion. Thirteen studies reported a single condition, and 17 studies reported on more than one condition (two to nine LTCs). Only seven studies examined the impact of comorbidities. Random effects meta-analyses were feasible for a subgroup of studies examining diabetes (four studies) or respiratory diseases (three studies) on DFLE. From pooled results, individuals at age 65 without diabetes gain on average 2.28 years disability-free compared to those with diabetes (95% CI: 0.57-3.99, p<0.01, I2 = 96.7%), whilst individuals without respiratory diseases gain on average 1.47 years compared to those with respiratory diseases (95% CI: 0.77-2.17, p<0.01, I2 = 79.8%). Eliminating diabetes, stroke, hypertension or arthritis would result in compression of disability. Of the seven longitudinal studies assessing the impact of multiple LTCs, three found that stroke had the greatest effect on DFLE for both genders. This study is the first to systematically quantify the impact of LTCs on both HE and LE at a global level, to assess potential compression of disability. Diabetes, stroke, hypertension and arthritis had a greater effect on DFLE than LE and so elimination would result in compression of disability. Guidelines for reporting HE outcomes would assist data synthesis in the future, which would in turn aid public health policy.
Identifiants
pubmed: 36962577
doi: 10.1371/journal.pgph.0000745
pii: PGPH-D-21-01155
pmc: PMC10021208
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000745Subventions
Organisme : The Dunhill Medical Trust
ID : RPGF1806/44
Pays : United Kingdom
Informations de copyright
Copyright: © 2022 Lourida et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Soc Sci Med. 1999 Feb;48(4):445-69
pubmed: 10075171
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
J Aging Health. 2014 Mar;26(2):261-82
pubmed: 24368296
Am J Public Health. 1996 Feb;86(2):187-94
pubmed: 8633734
Lancet Diabetes Endocrinol. 2016 Aug;4(8):686-694
pubmed: 27298181
Qual Life Res. 2019 Nov;28(11):3055-3064
pubmed: 31309398
J Clin Epidemiol. 1998 Apr;51(4):343-53
pubmed: 9539891
J Women Aging. 2002;14(1-2):61-83
pubmed: 12537280
JAMA. 2002 Dec 25;288(24):3137-46
pubmed: 12495394
Diabetes Care. 2018 May;41(5):1040-1048
pubmed: 29545462
Chronic Dis Inj Can. 2013 Mar;33(2):103
pubmed: 23470176
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Diabetes Care. 2016 Jul;39(7):1222-9
pubmed: 26721810
Health Promot Chronic Dis Prev Can. 2016 Oct;36(10):205-213
pubmed: 27768557
J Gerontol B Psychol Sci Soc Sci. 2010 May;65B(3):381-9
pubmed: 20028950
Am J Geriatr Psychiatry. 2008 May;16(5):425-32
pubmed: 18448853
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Disabil Rehabil. 1999 May-Jun;21(5-6):211-21
pubmed: 10381233
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Rev Saude Publica. 2013 Jun;47(3):514-22
pubmed: 24346564
PLoS One. 2016 Oct 19;11(10):e0165127
pubmed: 27760234
Lancet Diabetes Endocrinol. 2013 Oct;1(2):106-14
pubmed: 24622316
J Public Health Med. 2003 Mar;25(1):42-6
pubmed: 12669917
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Prev Med Rep. 2018 Oct 19;12:284-293
pubmed: 30406006
J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1331-1337
pubmed: 30247552
J Health Soc Behav. 2006 Jun;47(2):126-41
pubmed: 16821507
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Health Qual Life Outcomes. 2015 Oct 15;13:168
pubmed: 26467295
Age Ageing. 2018 May 01;47(3):374-380
pubmed: 29370339
Disabil Rehabil. 2009;31(9):701-11
pubmed: 18979275
BMJ. 2019 Mar 27;364:l969
pubmed: 30917970
J Am Geriatr Soc. 2019 Dec;67(12):2528-2536
pubmed: 31411348
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
J Gerontol. 1991 May;46(3):S170-82
pubmed: 2030287
Gerontologist. 2020 Jan 24;60(1):e52-e65
pubmed: 31002312
Obesity (Silver Spring). 2009 Feb;17(2):363-9
pubmed: 19023280
Cien Saude Colet. 2014 Aug;19(8):3327-34
pubmed: 25119072
Int J Environ Res Public Health. 2020 Jun 18;17(12):
pubmed: 32570985
J Aging Health. 2011 Apr;23(3):554-77
pubmed: 21139078
BMC Geriatr. 2019 Jan 18;19(1):16
pubmed: 30658578
Arthritis Rheumatol. 2014 Mar;66(3):622-36
pubmed: 24574223
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Arch Neurol. 2003 Feb;60(2):253-9
pubmed: 12580712
Int J Evid Based Healthc. 2015 Sep;13(3):147-53
pubmed: 26317388
Diabetologia. 2016 Jul;59(7):1437-1445
pubmed: 27075450
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
N Engl J Med. 2012 Mar 29;366(13):1209-17
pubmed: 22455415
Qual Life Res. 2010 Aug;19(6):781-7
pubmed: 20349211
J Gerontol A Biol Sci Med Sci. 2007 Apr;62(4):408-14
pubmed: 17452735
Int J Geriatr Psychiatry. 2008 Jun;23(6):643-9
pubmed: 18044794
Disabil Rehabil. 2016;38(4):354-61
pubmed: 25936731
J Aging Health. 2006 Aug;18(4):491-506
pubmed: 16835386